Jasper Therapeutics (JSPR) Current Leases (2021 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Current Leases of $1.2 million for Q4 2025, up 13.41% year-over-year from $1.1 million in Q4 2024, and down 27.48% quarter-over-quarter from $1.7 million in Q3 2025.
Jasper Therapeutics (JSPR) Current Leases (2021 - 2025) Analysis & Trends
Jasper Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Current Leases rose 13.41% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 13.41% YoY), while the FY2025 annual figure was $1.2 million, up 13.41% from the prior year.
- Current Leases for Q4 2025 stood at $1.2 million, down from $1.7 million in the prior quarter.
- The five-year high for Current Leases was $2.0 million in Q2 2025, with the low at $490000.0 in Q3 2021.
- The 5-year median for Current Leases is $958500.0 (2023), against an average of $1.0 million.
- The sharpest annual moves came in 2024 and 2025: Current Leases grew 12.04% in 2024, then jumped 89.89% in 2025.
- Jasper Therapeutics' Current Leases stood at $505000.0 in 2021, then soared by 71.29% to $865000.0 in 2022, then grew by 12.37% to $972000.0 in 2023, then gained by 12.04% to $1.1 million in 2024, then advanced by 13.41% to $1.2 million in 2025.
- Business Quant data shows JSPR's Current Leases at $1.2 million in Q4 2025, $1.7 million in Q3 2025, and $2.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Jasper Therapeutics | 20.06 Mn | 20.06 Mn | - | 270,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 972,000.00 |
| Sep 30, 2023 | 945,000.00 |
| Jun 30, 2023 | 917,000.00 |
| Mar 31, 2023 | 891,000.00 |
| Dec 31, 2022 | 865,000.00 |
| Sep 30, 2022 | 840,000.00 |
| Jun 30, 2022 | 784,000.00 |
| Mar 31, 2022 | 521,000.00 |
| Dec 31, 2021 | 505,000.00 |
| Sep 30, 2021 | 490,000.00 |